Q3 FY2024 · ended Sep 30, 2024 · Revenue $0 · Filed Nov 22, 2024
HST Global, Inc. (HSTC) files with the SEC under industry code 2834, Pharmaceutical Preparations. In Q3 of fiscal 2024, the quarter ended Sep 30, 2024, it reported revenue of $0 and a net loss of $13,792.
Revenue
$0
Net income
$-13,792
+61.4% vs year-ago quarter
Operating cash flow
$-18,549
-324.6% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
42.77M
+714.9% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HSTC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Virginia Beach, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 797564
- Former names
- NT HOLDING CORP. (until Mar 31, 2009); ABSS CORP (until Aug 12, 2004); UNICO INC (until May 22, 2002)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2024 Sep 30, 2024 |
Q2 FY2024 Jun 30, 2024 |
Q1 FY2024 Mar 31, 2024 |
Q4 FY2023 Dec 31, 2023 |
Q3 FY2023 Sep 30, 2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$13,400 | -$16,556 | -$32,688 | -$35,474 | -$34,368 |
| Net income | -$13,792 | -$16,640 | -$34,177 | -$36,899 | -$35,730 |
| Operating cash flow | -$18,549 | $18,517 | -$32,688 | -$5,473 | -$4,369 |
| Total assets | $1.3M | $5,155 | $838 | $1,526 | $2,000 |
| Total liabilities | $42,076 | $23,034 | $627,082 | $593,593 | $557,168 |
| Stockholders' equity | $1.2M | -$17,879 | -$626,244 | -$592,067 | -$555,168 |
| Cash and investments | $10,406 | $5,155 | $838 | $1,526 | $2,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Nov 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 20, 2025 | Mar 13, 2025 |
| 10-Q | Quarterly report | Nov 22, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 12, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 26, 2024 | Sep 25, 2024 |
| 10-Q | Quarterly report | Aug 26, 2024 | Jun 30, 2024 |
All 329 HST Global, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.